Myasthenia gravis and preeclampsia.
Myasthenia gravis in pregnancy is rare, and its occurence in conjunction with preeclampsia has not been previously described. A case report of preeclampsia in a myasthenic patient is described with recommendations for management. The authors conclude that magnesium is a contraindicated pharmacologic agent in a myasthenic patient.
D000328:Adult; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D007231:Infant, Newborn; D008278:Magnesium Sulfate / Q000009:adverse effects; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000150:complications* / Q000188:drug therapy; D011225:Pre-Eclampsia / Q000150:complications* / Q000188:drug therapy; D011247:Pregnancy; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012131:Respiratory Insufficiency / Q000188:drug therapy
D008750:Methyldopa; D008278:Magnesium Sulfate; D005665:Furosemide; D011729:Pyridostigmine Bromide